Literature DB >> 25192888

Microsatellite instability, promoter methylation and protein expression of the DNA mismatch repair genes in epithelial ovarian cancer.

Shilpa V1, Rahul Bhagat2, Premalata C S3, Pallavi V R4, Lakshmi Krishnamoorthy5.   

Abstract

The role of defective mismatch repair (MMR) system in ovarian carcinoma is not well defined. The purpose of the study was to determine the relationship between microsatellite instability (MSI), promoter methylation and protein expression of MMR genes in epithelial ovarian carcinoma (EOC). MSI and promoter methylation of MLH1, MSH2 and PMS2 genes were studied using PCR methods in the study cohort. A small subset of samples was used to analyze the protein expression by immunohistochemistry (IHC). MSI was observed in >60% of tumor samples and 47% of normal ovaries. MLH1 was methylated in 37.5% and 64.3% EOCs and LMP tumors. The loss of immunoexpression of MMR genes was not seen in ovarian tumors. There was no correlation between MSI, promoter methylation and protein expression of the MMR genes suggesting that each may function independently. MSI is a common event in ovarian carcinoma and may increase the clinical awareness of the subset of tumors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LOH; MMR; MSI; Ovarian cancer; Promoter methylation

Mesh:

Substances:

Year:  2014        PMID: 25192888     DOI: 10.1016/j.ygeno.2014.08.016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

Review 1.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

Review 2.  DNA methylation changes in epithelial ovarian cancer histotypes.

Authors:  Madalene A Earp; Julie M Cunningham
Journal:  Genomics       Date:  2015-09-10       Impact factor: 5.736

Review 3.  The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer.

Authors:  Dan Gao; James G Herman; Mingzhou Guo
Journal:  Oncotarget       Date:  2016-06-14

4.  Investigation of Cross-Contamination and Misidentification of 278 Widely Used Tumor Cell Lines.

Authors:  Yaqing Huang; Yuehong Liu; Congyi Zheng; Chao Shen
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

5.  Altered expression of the mismatch repair genes in DF-1 cells infected with the avian leukosis virus subgroup A.

Authors:  Da-Wei Yao; Li Zhan; Yu-Fang Hong; Jian-Xin Liu; Jia-Rong Xu; De-Ji Yang
Journal:  Springerplus       Date:  2016-10-07

6.  Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.

Authors:  Takashi Takeda; Kosuke Tsuji; Kouji Banno; Megumi Yanokura; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2018-01-30       Impact factor: 4.401

7.  Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers.

Authors:  Lorena Losi; Sergio Fonda; Sara Saponaro; Sonia T Chelbi; Cesare Lancellotti; Gaia Gozzi; Loredana Alberti; Luca Fabbiani; Laura Botticelli; Jean Benhattar
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

Review 8.  Epigenetic heterogeneity in cancer.

Authors:  Mingzhou Guo; Yaojun Peng; Aiai Gao; Chen Du; James G Herman
Journal:  Biomark Res       Date:  2019-10-31

Review 9.  Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability.

Authors:  Madhura Deshpande; Phillip A Romanski; Zev Rosenwaks; Jeannine Gerhardt
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

Review 10.  Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.

Authors:  Dionisia Quiroga; H Kim Lyerly; Michael A Morse
Journal:  Curr Treat Options Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.